Skip to content
MedsAcross

Manufacturer

Tolmar

Products listed
12
Molecules
2
Therapy areas
1

Tolmar is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 12 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
TOLMAR Inc.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Tolmar products through licensed channels, with the documents your regulator needs.

Oncology

9 presentations

Oncology overview
MedicineActive ingredientRegisterAvailability
Eligard kitSubcutaneous Cold chainLeuprolideUS FDAAvailable on request
Eligard kitSubcutaneous Cold chainLeuprolideUS FDAAvailable on request
Eligard kitSubcutaneous Cold chainLeuprolideUS FDAAvailable on request
Eligard kitSubcutaneous Cold chainLeuprolideUS FDAAvailable on request
Eligard 22.5 mg/0.375 mL extended-release injectable suspensionSubcutaneous Cold chainLeuprolideUS FDAAvailable on request
Eligard 30 mg/0.5 mL extended-release injectable suspensionSubcutaneous Cold chainLeuprolideUS FDAAvailable on request
Eligard 45 mg/0.375 mL extended-release injectable suspensionSubcutaneous Cold chainLeuprolideUS FDAAvailable on request
Eligard 7.5 mg/0.25 mL extended-release injectable suspensionSubcutaneous Cold chainLeuprolideUS FDAAvailable on request
Fensolvi 45 mg/0.375 mL extended-release injectable suspensionSubcutaneous Cold chainLeuprolideUS FDAAvailable on request

Other products

3 presentations

MedicineActive ingredientRegisterAvailability
Jatenzo 158 mg capsuleOralTestosterone undecanoateUS FDAAvailable on request
Jatenzo 198 mg capsuleOralTestosterone undecanoateUS FDAAvailable on request
Jatenzo 237 mg capsuleOralTestosterone undecanoateUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Tolmar

Send a request for any of these products. We confirm the licensed source, documents and lead time.